| Total (n = 596) | Responder (n = 268) | Non-responder (n = 328) | P value |
---|---|---|---|---|
Demographic characteristics | ||||
 Age | 61.67 ± 11.73 | 62.89 ± 11.04 | 60.67 ± 12.19 | 0.02 |
 Male | 431 (72.32%) | 175 (65.30%) | 256 (78.05%) | < 0.01 |
Past medical history | ||||
 Ischemic etiology | 54 (9.06%) | 16 (5.97%) | 38 (11.59%) | 0.03 |
 Hypertension | 241 (40.44%) | 118 (44.03%) | 123 (37.50%) | 0.13 |
 Diabetes mellitus | 110 (18.46%) | 55 (20.52%) | 55 (16.77%) | 0.29 |
 Atrial fibrillation | 121 (20.30%) | 47 (17.54%) | 74 (22.56%) | 0.16 |
 Prior CIED implantation | 46 (7.72%) | 16 (5.97%) | 30 (9.15%) | 0.20 |
 History of SCD | 67 (11.24%) | 24 (8.96%) | 43 (13.11%) | 0.14 |
 History of PCI | 41 (6.88%) | 10 (3.73%) | 31 (9.45%) | < 0.01 |
 History of CABG | 6 (1.01%) | 0 (0.00%) | 6 (1.83%) | 0.04 |
Clinical status | ||||
 NYHA class | 2.80 ± 0.67 | 2.75 ± 0.66 | 2.84 ± 0.68 | 0.11 |
 Weight (kg) | 66.32 ± 12.22 | 65.78 ± 12.11 | 66.78 ± 12.31 | 0.36 |
 SBP (mmHg) | 117.40 ± 18.28 | 119.93 ± 19.38 | 115.31 ± 17.07 | < 0.01 |
 DBP (mmHg) | 73.81 ± 10.37 | 74.35 ± 10.59 | 73.36 ± 10.17 | 0.25 |
Biochemical tests | ||||
 Hemoglobin (g/L) | 133.46 ± 17.22 | 132.91 ± 16.96 | 133.92 ± 17.44 | 0.48 |
 Lymphocytes (%) | 27.19 ± 9.43 | 28.05 ± 9.50 | 26.48 ± 9.33 | 0.04 |
 RDW-CV (%) | 13.82 ± 2.51 | 13.59 ± 3.14 | 14.00 ± 1.82 | 0.06 |
 RDW-SD (fL) | 46.48 ± 17.40 | 44.76 ± 4.94 | 47.88 ± 22.95 | 0.02 |
 Total bilirubin (μmol/L) | 16.42 ± 10.62 | 14.82 ± 9.58 | 17.73 ± 11.25 | < 0.01 |
 Combined bilirubin (μmol/L) | 7.18 ± 6.73 | 6.17 ± 6.03 | 8.01 ± 7.16 | < 0.01 |
 Albumin (g/L) | 40.40 ± 5.02 | 40.91 ± 5.45 | 39.97 ± 4.59 | 0.03 |
 Alanine transaminase (U/L) | 28.43 ± 34.30 | 24.61 ± 18.52 | 31.58 ± 42.94 | < 0.01 |
 Aspartate transaminase (U/L) | 26.97 ± 23.23 | 23.91 ± 11.60 | 29.49 ± 29.34 | < 0.01 |
 Blood urea nitrogen (mmol/L) | 7.79 ± 3.61 | 7.50 ± 3.49 | 8.02 ± 3.70 | 0.05 |
 Serum creatinine (μmol/L) | 93.48 ± 33.25 | 90.76 ± 30.98 | 95.74 ± 34.90 | 0.07 |
 eGFR (ml/min/1.73 m2) | 74.82 ± 24.36 | 75.21 ± 22.38 | 74.50 ± 25.92 | 0.72 |
 Serum uric acid (μmol/L) | 447.64 ± 133.83 | 427.14 ± 126.73 | 464.59 ± 137.33 | < 0.01 |
 Fasting glucose (mmol/L) | 5.87 ± 2.07 | 6.01 ± 2.28 | 5.75 ± 1.87 | 0.14 |
 Total cholesterol (mmol/L) | 4.13 ± 1.00 | 4.14 ± 1.00 | 4.13 ± 1.00 | 0.91 |
 Sodium (mmol/L) | 140.30 ± 3.97 | 140.72 ± 3.95 | 139.96 ± 3.95 | 0.02 |
 Creatine kinase (U/L) | 84.18 ± 88.84 | 80.40 ± 59.78 | 87.34 ± 107.25 | 0.34 |
 Creatine kinase-MB (U/L) | 12.43 ± 4.97 | 12.33 ± 4.51 | 12.50 ± 5.33 | 0.68 |
 C-reactive protein (mg/L) | 8.19 ± 16.46 | 7.19 ± 15.84 | 8.91 ± 16.90 | 0.27 |
 Hemoglobin A1c (%) | 6.34 ± 1.13 | 6.36 ± 1.22 | 6.32 ± 1.05 | 0.71 |
 cTnT (ng/ml) | 0.06 ± 0.14 | 0.06 ± 0.15 | 0.06 ± 0.12 | 0.60 |
 NT-proBNP (pg/ml) | 3867.71 ± 4795.63 | 3049.77 ± 3734.94 | 4521.55 ± 5415.93 | < 0.01 |
 Free triiodothyronine (pmol/L) | 4.09 ± 0.83 | 4.17 ± 0.78 | 4.02 ± 0.86 | 0.04 |
 Free thyroxine (pmol/L) | 17.97 ± 3.48 | 17.46 ± 3.17 | 18.40 ± 3.67 | < 0.01 |
 TSH (uIU/ml) | 3.62 ± 5.44 | 3.12 ± 3.22 | 4.03 ± 6.72 | 0.04 |
Electrocardiographic parameters | ||||
 Atrial fibrillation | 109 (18.29%) | 43 (16.04%) | 66 (20.12%) | 0.24 |
 QRS morphology |  |  |  | < 0.01 |
 LBBB | 391 (65.60%) | 213 (79.48%) | 178 (54.27%) |  |
 RBBB | 40 (6.71%) | 5 (1.87%) | 35 (10.67%) |  |
 IVCD | 133 (22.32%) | 38 (14.18%) | 95 (28.96%) |  |
 Paced | 30 (5.03%) | 11 (4.10%) | 19 (5.79%) |  |
 QRS duration (ms) | 163.95 ± 23.94 | 166.17 ± 21.66 | 162.14 ± 25.54 | 0.04 |
 RR interval (ms) | 847.10 ± 202.88 | 826.47 ± 189.64 | 863.88 ± 211.84 | 0.02 |
 Corrected QT interval (ms) | 488.54 ± 46.90 | 495.35 ± 47.49 | 483.00 ± 45.75 | < 0.01 |
Echocardiographic parameters | ||||
 LAD (mm) | 49.54 ± 8.42 | 47.09 ± 7.84 | 51.53 ± 8.37 | < 0.01 |
 LVEDD (mm) | 69.37 ± 10.01 | 67.40 ± 8.61 | 70.99 ± 10.76 | < 0.01 |
 LVESD (mm) | 58.36 ± 10.17 | 55.96 ± 9.25 | 60.32 ± 10.48 | < 0.01 |
 IVS (mm) | 9.33 ± 2.01 | 9.33 ± 1.85 | 9.32 ± 2.14 | 0.95 |
 LVPW (mm) | 9.30 ± 1.68 | 9.33 ± 1.62 | 9.28 ± 1.73 | 0.72 |
 PAP (mmHg) | 42.51 ± 15.34 | 39.95 ± 13.30 | 44.58 ± 16.54 | < 0.01 |
 LVEF (%) | 31.51 ± 7.25 | 31.22 ± 6.68 | 31.75 ± 7.68 | 0.37 |
 MR | 2.50 ± 0.93 | 2.38 ± 0.96 | 2.61 ± 0.89 | < 0.01 |
 TR | 1.69 ± 0.96 | 1.56 ± 0.87 | 1.80 ± 1.03 | < 0.01 |
Medication at discharge | ||||
 Diuretics | 525 (88.09%) | 230 (85.82%) | 295 (89.94%) | 0.16 |
 ACEI | 354 (59.40%) | 158 (58.96%) | 196 (59.76%) | 0.91 |
 ARB | 176 (29.53%) | 86 (32.09%) | 90 (27.44%) | 0.18 |
 ARNI | 2 (0.34%) | 1 (0.37%) | 1 (0.30%) | 1.00 |
 β-blocker | 530 (88.93%) | 240 (89.55%) | 290 (88.41%) | 0.76 |
 Spironolactone | 536 (89.93%) | 245 (91.42%) | 291 (88.72%) | 0.34 |
 Ivabradine | 99 (16.61%) | 50 (18.66%) | 49 (14.94%) | 0.27 |
 Digoxin | 153 (25.67%) | 53 (19.78%) | 100 (30.49%) | < 0.01 |
 Amiodarone | 103 (17.28%) | 27 (10.07%) | 76 (23.17%) | < 0.01 |
 Statin | 155 (26.01%) | 70 (26.12%) | 85 (25.91%) | 1.00 |
 Warfarin | 77 (12.92%) | 30 (11.19%) | 47 (14.33%) | 0.31 |